Co-Pay Relief Program Announces Assistance for a New Disease Area

… Program eases cost burden for patients with pancreatic cancer

PAF’s Co-Pay Relief (CPR) program is pleased to announce that assistance will now be available to patients with pancreatic cancer through the launch of a new disease fund that can provide direct payment for co-payments, co-insurance and deductibles required by the patient’s insurer for medications prescribed to treat and manage their disease.

Specific information relative to the pancreatic cancer fund is provided below: 

Maximum annual award level: $8,000

Eligibility criteria:

  • Patient must be covered by Medicare, Medicaid, or Military Benefits, and insurance must cover the medication for which patient seeks assistance.
  • Patient must have a confirmed diagnosis of pancreatic cancer.
  • Patient must reside and receive treatment in the United States.
  • Patient’s income must fall below 400% of the Federal Poverty Guideline (FPG) with consideration of the Cost of Living Index (COLI) and the number in the household.

The Co-Pay Relief Program may help with all therapeutic and supportive medications, including generic or bioequivalent products prescribed to treat and/or manage the patient’s disease or condition. The program helps patients on a first-come, first-serve basis and processes applicants in the order in which their completed applications are received.                 

To apply for assistance please visit, with access available for patients, providers and pharmacies, or connect with our team via phone at 866-512-3861.